Enlivex Therapeutics
ENLV
ENLV
11 hedge funds and large institutions have $404K invested in Enlivex Therapeutics in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
71% less capital invested
Capital invested by funds: $1.4M → $404K (-$995K)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$30.7K | |
| 2 | +$17K | |
| 3 | +$17K | |
| 4 |
FPF
FNY Partners Fund
New York
|
+$13K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$11K |
Top Sellers
| 1 | -$334K | |
| 2 | -$282K | |
| 3 | -$214K | |
| 4 |
OC
Oppenheimer & Co
New York
|
-$7.99K |
| 5 |
Morgan Stanley
New York
|
-$1K |